Income tax expense · 2011–2025
Biomarin Pharmaceutical income tax expense
$134M+16.3% · FY2025
Biomarin Pharmaceutical (BMRN) reported $134M in income tax expense for fiscal 2025, +16.3% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $134M | +16.3% | Open → |
| FY20242024-12-31 | $115M | +449.3% | Open → |
| FY20232023-12-31 | $20.9M | +161.0% | Open → |
| FY20222022-12-31 | $8.0M | +$19.3M | Open → |
| FY20212021-12-31 | −$11.3M | +$892M | Open → |
| FY20202020-12-31 | −$903M | −$832M | Open → |
| FY20192019-12-31 | −$71.0M | −$5.5M | Open → |
| FY20182018-12-31 | −$65.5M | −$147M | Open → |
| FY20172017-12-31 | $81.2M | +$282M | Open → |
| FY20162016-12-31 | −$201M | −$218M | Open → |
| FY20152015-12-31 | $17.1M | +87.6% | Open → |
| FY20142014-12-31 | $9.1M | +$9.3M | Open → |
| FY20132013-12-31 | −$150,000 | +$3.8M | Open → |
| FY20122012-12-31 | −$3.9M | −$14.1M | Open → |
| FY20112011-12-31 | $10.2M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +20.2%
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biomarin Pharmaceutical income tax expense |url=https://companiesranked.com/en/company/biomarin-pharmaceutical/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biomarin Pharmaceutical income tax expense. CompaniesRanked. https://companiesranked.com/en/company/biomarin-pharmaceutical/income-tax-expenseBibTeX
@misc{companiesranked-en-company-biomarin-pharmaceutical-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Biomarin Pharmaceutical income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biomarin-pharmaceutical/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001048477-26-000004 · February 26, 2026
{{cite web |title=Biomarin Pharmaceutical income tax expense — 10-K (0001048477-26-000004) |url=https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.